Scarica l'app Stockscreener
41.39
1.31%
-0.55
Precedente Chiudi:
$41.94
Aprire:
$42.11
Volume 24 ore:
444.37K
Capitalizzazione di mercato:
$2.26B
Reddito:
-
Utile/perdita netta:
$-95.99M
Rapporto P/E:
-12.32
EPS:
-3.36
Flusso di cassa netto:
$-92.18M
1 W Prestazione:
+0.17%
1M Prestazione:
+3.45%
6M Prestazione:
+202.34%
1 anno Prestazione:
+445.32%
Intervallo 1D:
$40.92
$42.26
Portata 52W:
$7.10
$50.78
Vera Therapeutics Inc Stock (VERA) Company Profile
Nome
Vera Therapeutics Inc
Settore
Industria
Telefono
650-770-0077
Indirizzo
170 Harbor Way, 3rd Floor, South San Francisco
Vera Therapeutics Inc Stock (VERA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-01-25 | Iniziato | Oppenheimer | Outperform |
| 2024-01-08 | Iniziato | Cantor Fitzgerald | Overweight |
| 2023-12-18 | Iniziato | Raymond James | Outperform |
| 2023-11-10 | Aggiornamento | Jefferies | Hold → Buy |
| 2023-08-16 | Iniziato | Guggenheim | Buy |
| 2023-01-04 | Downgrade | Jefferies | Buy → Hold |
| 2023-01-04 | Downgrade | Wedbush | Outperform → Neutral |
| 2022-07-12 | Iniziato | JP Morgan | Overweight |
| 2022-05-02 | Iniziato | H.C. Wainwright | Buy |
| 2022-04-19 | Iniziato | Wedbush | Outperform |
Mostra tutto
Vera Therapeutics Inc Borsa (VERA) Ultime notizie
Novartis deal for Chinook makes kidney-treatment competitors more attractive, analysts say - MSN
MSN
Vera Therapeutics executive trades shares worth over $1.3 million - Investing.com Australia
Investing.com Australia
Vera Therapeutics executive trades shares worth over $1.3 million - Investing.com India
Investing.com India
Vera Therapeutics executive trades shares worth over $1.3 million - Investing.com
Investing.com
New York State Common Retirement Fund Increases Stock Position in Vera Therapeutics, Inc. (NASDAQ:VERA) - Defense World
Defense World
Vera Therapeutics, Inc. (NASDAQ:VERA) Given Consensus Recommendation of “Buy” by Brokerages - Defense World
Defense World
Vera Therapeutics Inc Azioni (VERA) Dati Finanziari
Vera Therapeutics Inc (VERA) Reddito netto 2024
VERA l'utile netto (TTM) è stato di -$95.99 milioni per il trimestre terminato il 2023-12-31, un -7.79% diminuire anno su anno.
Vera Therapeutics Inc (VERA) Flusso di cassa 2024
VERA ha registrato un flusso di cassa disponibile (TTM) di -$92.18 milioni per il trimestre conclusosi con 2023-12-31, un -36.25% diminuire anno su anno.
Vera Therapeutics Inc (VERA) Utile per azione 2024
L'utile per azione (TTM) di VERA è stato pari a -$2.29 per il trimestre terminato il 2023-12-31, un +31.85% crescita anno su anno.
Vera Therapeutics Inc Azioni (VERA) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Young Joseph R | SVP, FINANCE, CHIEF ACCT OFFCR |
May 16 '24 |
Sale |
42.32 |
20,651 |
873,890 |
51,206 |
| Young Joseph R | SVP, FINANCE, CHIEF ACCT OFFCR |
May 15 '24 |
Option Exercise |
3.94 |
8,221 |
32,387 |
61,392 |
| Young Joseph R | SVP, FINANCE, CHIEF ACCT OFFCR |
May 15 '24 |
Sale |
42.27 |
10,186 |
430,546 |
51,206 |
| Young Joseph R | SVP, FINANCE, CHIEF ACCT OFFCR |
Apr 10 '24 |
Sale |
40.00 |
5,714 |
228,560 |
53,171 |
| Grant Sean | CHIEF FINANCIAL OFFICER |
Apr 03 '24 |
Option Exercise |
14.87 |
99,828 |
1,484,442 |
166,165 |
| Grant Sean | CHIEF FINANCIAL OFFICER |
Apr 03 '24 |
Sale |
39.61 |
99,828 |
3,954,516 |
66,337 |
| Grant Sean | CHIEF FINANCIAL OFFICER |
Apr 03 '24 |
Sale |
39.42 |
18,649 |
735,205 |
0 |
| Katabi Maha | Director |
Mar 25 '24 |
Sale |
40.50 |
340,000 |
13,770,000 |
2,793,987 |
| Katabi Maha | Director |
Mar 22 '24 |
Sale |
40.51 |
413,450 |
16,748,860 |
3,133,987 |
| Katabi Maha | Director |
Mar 21 '24 |
Sale |
44.20 |
81,009 |
3,580,723 |
3,547,437 |
0.77%
1.20%
Capitalizzazione:
|
Volume (24 ore):